PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours.

The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for treating urinary urge incontinence (UUI).

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m) after a report found that 87% of public procurement contracts for medical ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT technology.

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid leukaemia (AML).

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of individuals with MPNs ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, GenomicsNext.

Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s pre-specified analysis.

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform.

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system begins.

InspireMD’s CGuard Prime Embolic Prevention System (EPS) has secured CE Mark approval under the European MDR for stroke prevention.